Emerging role for microRNAs in acute promyelocytic leukemia

Current Topics in Microbiology and Immunology

Volumn 313, Issue , 2007, Pages 73-84

  Nervi, C ^a   Fazi, F ^a   Rosa, A ^a   Fatica, A ^a   Bozzoni, I ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; DNA; HISTONE; MICRORNA; NUCLEAR FACTOR I; RETINOIC ACID; RNA; TRANSCRIPTION FACTOR; VITAMIN D;

APOPTOSIS; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CELL SPECIFICITY; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMOSOME TRANSLOCATION; DEVELOPMENT; DNA METHYLATION; DNA SEQUENCE; EPIGENETICS; GENE EXPRESSION; GRANULOCYTE; HEMATOPOIESIS; HEMATOPOIETIC CELL; HUMAN; LEUKEMIA; NONHUMAN; NUCLEOSOME; PATHOGENESIS; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN PROCESSING; REVIEW; TISSUE SPECIFICITY; TRANSCRIPTION REGULATION; TUMOR GROWTH; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; GENE EXPRESSION REGULATION; HEMATOPOIESIS; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MICRORNAS; NFI TRANSCRIPTION FACTORS;

EID: 33847004435     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-540-34594-7_5     Document Type: Review

References (33)

1. Ambros V (2004) The function of animal miRNAs. Nature 431:350-355
2. Bartell DP (2004) MicroRNAs: genomics, biogenesis, mechanism and function. Cell 116:281-297
3. Caldas C, Brenton JD (2005) Sizing up miRNAs as cancer genes. Nat Med 11:712-714
4. Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M, Wojcik SE, Iorio MV, Visone R, Sever NI, Fabbri M, Iuliano R, Palumbo T, Pichiorri F, Roldo C, Garzon R, Sevignani C, Rassenti L, Alder H, Volinia S, Liu CG, Kipps TJ, Negrini M, Croce CM (2005) A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 353:1793-1801
5. Chen CZ (2005) MicroRNAs as oncogenes and tumor suppressors. N Engl J Med 353:1768-1771
6. Chen CZ, Li L, Lodish HF, Bartell DP (2004) MicroRNAs modulate hematopoietic lineage differentiation. Science 303:83-86
7. Di Croce L, Raker VA, Corsaro M, Fazi F, Fanelli M, Faretta M, Fuks F, Lo Coco F, Kouzarides T, Nervi C, Minucci S, Pelicci PG (2002) Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor. Science 295:1079-1082
8. Fazi F, Rosa A, Fatica A, Gelmetti V, De Marchis ML, Nervi C, Bozzoni I (2005) A mini-circuitry comprising microRNA-223 and transcription factors NFI-A and C/EBPα regulates human granulopoiesis. Cell 123:819-831
9. Felli N, Fontana L, Pelosi E, Botta R, Bonci D, Facchiano F, Liuzzi F, Lulli V, Morsilli O, Santoro S, Valtieri M, Calin GA, Liu CG, Sorrentino A, Croce CM, Peschle C (2005) MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via Kit receptor downmodulation. Proc Natl Acad Sci U S A 102:18081-18086
10. Ferrara FF, Fazi F, Bianchini A, Padula F, Gelmetti V, Minucci S, Mancini M, Pelicci PG, Lo Coco F, Nervi C (2001) Histone deacetylase targeted treatment restores retinoic acid signaling and differentiation in acute myeloid leukemia. Cancer Res 61:2-7
11. Filipowicz W (2005) RNAi: the nuts and bolts of the RISC machine. Cell 122:17-20
12. Garlatti M, Tchesnokov V, Daheshia M, Feilleux-Duche S, Hanoune J, Aggerbeck M, Barouki R (1993) CCAAT/enhancer-binding protein-related proteins bind to the unusual promoter of the aspartate aminotransferase housekeeping gene. J Biol Chem 268:6567-6574
13. Gronostajski RM (2000) Roles of the NF1/CTF gene family in transcription and development. Gene 249:31-45
14. Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M, Rajewsky N (2005) Combinatorial microRNA target predictions. Nat Genet 37:495-500
15. Lee YS, Nakahara K, Pham JW, Kim K, He Z, Sontheimer EJ, Carthew RW (2004) Distinct roles for Drosophila Dicer-1 and Dicer-2 in the siRNA/miRNA silencing pathways. Cell 117:69-81
16. Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120:15-20
17. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR, Golub TR (2005) MicroRNA expression profiles classify human cancers. Nature 435:834-838
18. Meister G, Tuschl T (2004) Mechanisms of gene silencing by double-stranded RNA. Nature 431:343-349
19. Meisterernst M, Gander I, Rogge L, Winnacker EL (1988) A quantitative analysis of nuclear factor I/DNA interactions. Nucleic Acids Res 16:4419-4435
20. Melnick A, Licht JD (1999) Deconstructing a disease: RARα, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood 93:3167-3215
21. Okamura K, Ishizuka A, Siomi H, Siomi MC (2004) Distinct roles for Argonaute proteins in small RNA-directed RNA cleavage pathways. Genes Dev 18:1655-1666
22. Pasquinelli AE, Hunter S, Bracht J (2005) MicroRNAs: a developing story. Curr Opin Genet Dev 15:200-205
23. Rabbitts TH (1994) Chromosomal translocations in human cancer. Nature 372:143-149
24. Radomska HS, Huettner CS, Zhang P, Cheng T, Scadden DT, Tenen DG (1998) CCAAT/enhancer binding protein alpha is a regulatory switch sufficient for induction of granulocytic development from bipotential myeloid progenitors. Mol Cell Biol 18:4301-4314
25. Salomoni P, Pandolfi PP (2000) Transcriptional regulation of cellular transformation. Nat Med 6:742-744
26. Sanz MA, Tallman MS, Lo-Coco F (2005) Tricks of the trade for the appropriate management of newly diagnosed acute promyelocytic leukemia. Blood 105:3019-3025
27. Shao W, Benedetti L, Lamph WW, Nervi C, Miller WHJ (1997) A retinoid-resistant acute promyelocytic leukemia subclone expresses a dominant negative PMLRARα mutation. Blood 89:4282-4289
28. Sontheimer EJ, Carthew RW (2005) Silence from within: endogenous siRNAs and miRNAs. Cell 122:9-12
29. Tenen DG (2003) Disruption of differentiation in human cancer: AML shows the way. Nat Rev Cancer 3:89-101
30. Tenen DG, Hromas R, Licht JD, Zhang DE (1997) Transcription factors, normal myeloid development, and leukemia. Blood 90:489-519
31. Truong BT, Lee YJ, Lodie TA, Park DJ, Perrotti D, Watanabe N, Koeffler HP, Nakajima H, Tenen DG, Kogan SC (2003) CCAAT/Enhancer binding proteins repress the leukemic phenotype of acute myeloid leukemia. Blood 101:1141-1148
32. Tsai S, Bartelmez S, Heyman RA, Damm K, Evans RM, Collins SJ (1992) A mutated retinoic acid receptor-α exhibiting dominant-negative activity alters the lineage development of a multipotent hematopoietic cell line. Genes Dev 6:2258-2269
33. Zhang DE, Zhang P, Wang ND, Hetherington CJ, Darlington GJ, Tenen DG (1997) Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice. Proc Natl Acad Sci U S A 94:569-574